Skip to main content
. 2019 May 17;9:7532. doi: 10.1038/s41598-019-43992-z

Figure 6.

Figure 6

Dab2 promoter methylation in pancreatic tumor samples and pancreatic cancer cell lines. (a,c) Genomic DNA was isolated from the indicated pancreatic cancer cell lines and the normal or tumor pancreatic tissue samples as described under Methods. Following bisulfite modification of the DNA, methylation-specific PCR was performed using primers corresponding to unmethylated (U) and methylated (M) sequences derived from exon 2 of the Dab2 gene promoter. PCR products were separated on a 2% agarose gel and visualized by EtBr staining. (b) MiaPaCa2 cells were untreated or treated with 5-aza-2′deoxycytidine (Aza), trichostatin A (TSA) or the combination (Aza + TSA) as described in Methods. Following treatment, mRNA was isolated and qRT-PCR was performed to determine mRNA expression of Dab2 and E-cadherin. Relative expression is shown, with mRNA levels in untreated MiaPaCa2 cells set to 1.0. Shown is the mean relative expression level ± SD performed in triplicate. * signifies p < 0.05.